INVESTOR RELATIONS
UV-Clear™ is an American hardware company behind an LED-based device that’s economically designed to treat the most threatening airborne viruses.
Built and developed by leading engineers across semiconductor, submarine, and LED systems.
Retrofit First
Easily installs in virtually any existing HVAC system. No upgrades, no redesign, no disruption.
Easy Install
One six-inch hole. Using existing power. Any licensed HVAC technician.
Patent Protected
Issued U.S. Patent US 12,588,134 B2
Super Efficient
Our patented passive cooling platform addressed the historic LED thermal limitations.
Built on Nichia
Proudly built on Nichia UV LEDs. World's leading LED manufacturer
Lab Tested
Multi-phase third-party calibration testing underway. Phase one results are in!
PANDEMIC-READY PURIFICATION
Always-on UV-C protection; pathogen-agnostic, continuously working, built for the next threat before it arrives.
SUSTAINABLE
BY DESIGN
No mercury disposal liability. No energy penalty. UV-Clear™ improves indoor air quality without adding to your environmental footprint.
OCCUPANT SAFE.
PATHOGEN LETHAL.
UV-C operates entirely inside the ductwork. Zero exposure risk to occupants, staff, students, or patients. Germicidal by design. Safe by design.
READY FOR TOMORROW
AND BEYOND
Regulators are pushing out Mercury UV-C. UV-Clear™ is mercury-free, regulation-proof, and built for the infrastructure reality that follows.
The Best of Both Worlds
Effective + Efficient.
You can now have both.
Most IAQ upgrades force a choice, better air or lower energy burden. UV-Clear™ doesn't. Directional UV-C output, passive cooling, and zero fan load penalty mean the system that cleans your air is also the one that costs you the least to run.
Our IP
UV-Clear™ proof
Real validation. Issued IP. Independent lab.
UV-Clear™ was tested against ASHRAE 185.1/2 standards with no PTFE reflective materials added to the duct and no burn-in where the device is running before measurement begins. To our knowledge, we are the first UV-C device tested in this manner which was designed to simulate real-world installations and field deployments across all moving air environments. UV-Clear™’s prototype device, under 50% power load, was certified by AirMid to provide a 64% first-pass inactivation of MS2 bacteriophage at 2000 CFM. High-power MS2 and H1N1 validation is ongoing.
OUR PATENT
UV-Clear™ also holds an issued U.S. utility patent, US 12,588,134 B2, covering the passive cooling approach that makes dense UV-C LED arrays viable in moving air. Additional testing is underway, including H1N1 on both high and low power settings for ASHRAE 241 Schedule F procurement compliance.
UV-Clear™ Proof
64% MS2 reduction
Single pass, low power, prototype in calibration
ASHRAE 185.1-2020 methodology
Issued U.S. Patent US 12,588,134 B2
Independent lab
Airmid Healthgroup, Dublin, Ireland
Additional pathogen testing underway
Where We Stand
Validated.
But we'd like to push for additional testing
COMPLETE
Preliminary ASHRAE 185.1-2020 calibration
UV-Clear™ was tested against ASHRAE 185.1/2 standards with no PTFE reflective materials added to the duct and no burn-in where the device is running before measurement begins. To our knowledge, we are the first UV-C device tested in this manner which was designed to simulate real-world installations and field deployments across all moving air environments. UV-Clear™s prototype device, under 50% power load, was certified by AirMid to provide a 64% first-pass inactivation of MS2 bacteriophage at 2000 CFM
This is a first data point from a prototype still in calibration, an opening result, not a finished spec. More is on the way.
PHASE 2 TESTING UNDERWAY
ASHRAE 241 Schedule F compliance
H1N1 testing on both high and low power settings is actively in progress, specifically targeting ASHRAE 241 Schedule F procurement compliance. Schedule F is the standard your institutional procurement team will require before approving a germicidal UV specification. We are not claiming 241 compliance today. We are showing you the testing roadmap, where we are on it, and what comes next.
ISSUED
IP position
The core thermal innovation is protected by an issued U.S. utility patent US 12,588,134 B2. The patent covers the passive cooling approach that makes dense UV-C LED arrays viable in fast-moving air. This is the barrier that separates UV-Clear™ from off-the-shelf LED products that burn out under real duct conditions.
WORKING HYPOTHESIS 30–50
Equivalent Air Exchange (eACH)
Based on system geometry, airflow parameters, and first-pass test results, our current scientific and mathematical hypothesis places UV-Clear™'s equivalent clean air delivery contribution in the 30–50 eACH range for standard commercial duct configurations. This is a working projection, not yet a certified figure, it will be validated and refined as Phase 2 testing progresses. We're telling you the hypothesis now because compliance buyers deserve to know the number we're working toward, not just that we're "testing."
MANUFACTURE-READY
The platform design is finalized
The product line - ClearFlow 120, ClearFlow 240, ClearFlow 480, is production-ready across small commercial to large institutional air handler configurations. You are not buying a concept or a prototype pipeline.
You are engaging with a production-ready system that is still accumulating proof points.
UV-Clear™ + our Programmatic Partners
